Dalrada Financial Reports Q2 2024: Revenue Declines and Increased Losses Amidst Mixed Performance

Dalrada Financial Corporation (PINK: DFCO) - Analysis of Financial Results (Q2 2024)

Dalrada Financial Corporation has reported its Q2 2024 financial results, providing insight into its financial health and operational performance. Here are the key highlights from the income statement:

• Total Revenues: $4,357,316 in Q2 2024, down from $5,253,120 in Q2 2023, a decline of approximately 17%.
• Revenue Breakdown:
  • Genefic: $2,831,349 (41% increase from previous year)
  • Dalrada Climate Technology: $640,051 (63% decrease)
  • Dalrada Precision Manufacturing: $592,035 (42.8% decrease)
  • Dalrada Technologies: $293,881 (39% decrease)
• Cost of Revenues: Increased to $3,911,652 from $2,955,132 year-over-year, leading to reduced gross profit.
• Gross Profit: $445,664, significantly down from $2,297,988 in the same quarter last year.
• Operating Expenses: $6,227,434, a decrease from $7,080,077, reflecting efforts to control costs despite ongoing losses.
• Loss from Operations: Increased to $(5,781,770) from $(4,782,089) year-over-year.
• Net Loss: $(6,996,276) compared to $(4,482,165), indicating deteriorated profitability.
• Additional Financial Metrics: Net loss per share was $(0.08), and cash and cash equivalents amounted to $598,438.

Positive Aspects:

• Revenue from the Genefic segment increased substantially, highlighting growth in healthcare solutions.
• Effective management of operating expenses, with a slight reduction despite high overall losses.

Negative Aspects:

• Overall revenue decline affects the sustainability of growth and operational viability.
• Significant losses indicate liquidity challenges, with a working capital deficit of $2,681,448 as of December 31, 2023.
• High cost of revenues increased far more significantly than revenues, compressing margins.

In summary, while Dalrada Financial Corporation shows positive growth in some areas like its Genefic segment, it faces significant challenges with overall revenue decline, increasing operational losses, and a critical need for additional financing to support its growth plans.